Casey Hoyt is the CEO of Viemed Healthcare, Inc., a company that's focused on improving respiratory care in the United States. He has a solid background in healthcare, having founded two subsidiaries in 2006 that eventually sold to PHM. After...

Casey Hoyt is the CEO of Viemed Healthcare, Inc., a company that's focused on improving respiratory care in the United States. He has a solid background in healthcare, having founded two subsidiaries in 2006 that eventually sold to PHM. After the spinout in 2017, he took the helm of Viemed to further enhance patient lives through clinical excellence and innovation. Casey studied at Harvard Business School, which plays a big part in his strategic decisions. In 2023, he was compensated over $2.5 million, a significant jump reflecting his leadership role in the company. He’s known for his hands-on approach, consistently setting and exceeding goals in a complex industry. Interestingly, his stock holdings have seen a fluctuation in value, reflecting the company's growth journey. His efforts have not only focused on business success; they also aim to provide better healthcare access, showing that profit and purpose can go hand in hand.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

V

Casey Hoyt

Founder and CEO of Viemed Healthcare, Inc.

Education

Bachelor of Science in General Studies from the University of Louisiana at Lafayette

Field of Expertise

Business & Management

Sector of Economy

Healthcare

CEO of Viemed Healthcare, Inc. for

7 years 5 months (Dec 2017 - Present)

Previous Experience

Co-founded Sleep Management, L.L.C. and Home Sleep Delivered, L.L.C.

Rivals

Competitors/colleagues of Casey Hoyt

Holdings

See how much did Casey Hoyt make over time.

Casey Hoyt's stock holdings in Viemed Healthcare have seen notable changes over the years. In 2019, his holdings were valued at around $18.14 million, reflecting a strong confidence in his company's direction. They peaked at $23.04 million in April 2023,...

Casey Hoyt's stock holdings in Viemed Healthcare have seen notable changes over the years. In 2019, his holdings were valued at around $18.14 million, reflecting a strong confidence in his company's direction. They peaked at $23.04 million in April 2023, showcasing the trust in Viemed’s potential. However, by the end of 2023, this value adjusted to around $16.95 million, illustrating the market's fluctuation. It's interesting to note that a significant part of his total wealth is tied to these shares, which links his personal financial outlook with the company’s performance. This connection is vital in motivating both him and the entire team towards achieving long-term growth and stability in a competitive industry. The volatility in valuations highlights the challenges in the healthcare sector but also emphasizes the upside potential as the company expands its reach.

Mar 18, 2025

V

shares

VMD @ $7.49

Charitable Transactions

VMD

2,046,943 shares

VMD

Recent Charitable Transactions

VMD

26,000 shares

VMD

Mar 22, 2024

Charity

VMD

2,010,943 shares

VMD

Aug 14, 2023

Charity

VMD

10,000 shares

VMD

May 11, 2021

Charity

Insider Trading

See recent insider trades of Casey Hoyt.

VMD

26,000 shares

VMD

Mar 22, 2024

Charity

VMD

2,010,943 shares

VMD

Aug 14, 2023

Charity

VMD

2,010,943 shares

VMD

Aug 14, 2023

Charity

VMD

10,000 shares

VMD

May 11, 2021

Charity

Compensation History

See how much did Casey Hoyt make over time.

In 2023, Casey Hoyt received a total compensation of $2,512,214. This included a base salary of $509,277 and a bonus of $4,544, which is tied to the performance metrics set by the Compensation Committee. Additionally, he received about $24,623 in other benefits, such as contributions to a 401(k) plan and insurance premiums. Compared to previous years, this was a notable increase in pay, due mainly to Viemed's robust performance during that period. His total compensation trajectory showcases his role’s importance in aligning his incentives with the shareholders' interests. Notably, Hoyt's compensation structure aims to reflect not just the financial success of Viemed, but also the operational goals reached, making it an integral part of his position.

Year

2023

Total Compensation

$538.44K

Salary

$509.28K

Board Justification

The compensation philosophy aims to attract and retain qualified executives while aligning their interests with those of shareholders through a competitive compensation package that includes base salary, performance incentives, and long-term equity-based incentives.

Bonus

$4.54K

Board Justification

The bonus is based on the Cash Bonus Plan, with a target bonus amount equal to 100% of annual base salary and a maximum bonus amount equal to 150% of annual base salary, reflecting performance metrics established by the Compensation Committee.

Other

$24.62K

Board Justification

Other compensation includes matching contributions under the 401(k) plan, medical insurance premiums, and life insurance premiums.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock was vested in 2023 as the amounts provided are for stock awards and options that are not included in total compensation calculations.

Performance Metrics

Performance metrics include financial and operational goals such as adjusted EBITDA, revenue, business line growth, and other corporate goals.